360.85
前日終値:
$359.97
開ける:
$362.51
24時間の取引高:
366.65K
Relative Volume:
0.98
時価総額:
$40.82B
収益:
$5.76B
当期純損益:
$514.49M
株価収益率:
80.52
EPS:
4.4813
ネットキャッシュフロー:
$1.10B
1週間 パフォーマンス:
+2.85%
1か月 パフォーマンス:
-4.12%
6か月 パフォーマンス:
+27.31%
1年 パフォーマンス:
+9.78%
Beone Medicines Ltd Adr Stock (ONC) Company Profile
名前
Beone Medicines Ltd Adr
セクター
電話
41-616851900
住所
C/O BEONE MEDICINES I GMBH, BASEL
Compare ONC vs VRTX, REGN, MRNA, ARGX, RVMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
ONC
Beone Medicines Ltd Adr
|
360.85 | 40.82B | 5.76B | 514.49M | 1.10B | 4.4813 |
|
VRTX
Vertex Pharmaceuticals Inc
|
526.19 | 133.37B | 12.34B | 4.34B | 3.71B | 16.87 |
|
REGN
Regeneron Pharmaceuticals Inc
|
788.04 | 81.13B | 14.92B | 4.42B | 3.79B | 41.04 |
|
MRNA
Moderna Inc
|
198.88 | 79.40B | 2.23B | -3.19B | -1.60B | -8.1462 |
|
ARGX
Argen X Se Adr
|
959.49 | 60.03B | 4.16B | 1.29B | 734.26M | 19.58 |
|
RVMD
Revolution Medicines Inc
|
204.97 | 43.93B | 742.00K | -1.37B | -1.07B | -7.0731 |
Beone Medicines Ltd Adr Stock (ONC) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-03-27 | 開始されました | Wolfe Research | Outperform |
| 2026-03-16 | ダウングレード | Jefferies | Buy → Hold |
| 2025-11-24 | 開始されました | Truist | Buy |
| 2025-09-18 | 開始されました | Barclays | Overweight |
| 2025-04-07 | 開始されました | RBC Capital Mkts | Outperform |
| 2025-03-03 | アップグレード | BofA Securities | Neutral → Buy |
| 2024-12-03 | 再開されました | Morgan Stanley | Overweight |
| 2024-09-18 | 開始されました | JMP Securities | Mkt Outperform |
| 2024-02-06 | 再開されました | JP Morgan | Overweight |
| 2023-09-12 | 開始されました | Macquarie | Outperform |
| 2023-08-17 | 開始されました | Jefferies | Buy |
| 2023-07-17 | 開始されました | Citigroup | Buy |
| 2023-06-30 | ダウングレード | Bernstein | Outperform → Mkt Perform |
| 2023-01-12 | 開始されました | Daiwa Securities | Buy |
| 2022-10-13 | アップグレード | Guggenheim | Neutral → Buy |
| 2022-10-13 | アップグレード | SVB Leerink | Mkt Perform → Outperform |
| 2022-08-09 | 再開されました | JP Morgan | Overweight |
| 2022-03-17 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2022-02-07 | 開始されました | Deutsche Bank | Buy |
| 2021-10-12 | 開始されました | Bernstein | Outperform |
| 2021-10-06 | アップグレード | CLSA | Underperform → Buy |
| 2021-03-08 | 開始されました | China Renaissance | Buy |
| 2021-03-01 | ダウングレード | CLSA | Outperform → Underperform |
| 2020-11-09 | ダウングレード | Ladenburg Thalmann | Buy → Neutral |
| 2020-11-06 | ダウングレード | Maxim Group | Buy → Hold |
| 2020-11-06 | ダウングレード | Piper Sandler | Neutral → Underweight |
すべてを表示
Beone Medicines Ltd Adr (ONC) 最新ニュース
Nykredit A S Buys New Position in BeOne Medicines Ltd.Sponsored ADR $ONC - marketbeat.com
Engineers Gate Manager LP Acquires New Position in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Xiaodong Wang Sells 38,287 Shares of BeOne Medicines (NASDAQ:ONC) Stock - marketbeat.com
Squarepoint Ops LLC Boosts Stock Position in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Baird Financial Group Inc. Raises Position in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Nykredit A S Invests $1.20 Million in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Public Employees Retirement System of Ohio Invests $2.14 Million in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
BeOne Medicines Ltd.Sponsored ADR (NASDAQ:ONC) Receives Average Recommendation of "Buy" from Brokerages - MarketBeat
B. Metzler seel. Sohn & Co. AG Has $1.91 Million Stock Position in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
BeOne Medicines (NASDAQ:ONC) Insider Sells $46,973.52 in Stock - MarketBeat
BeOne Medicines stock rises nearly 4% as buyers control session amid bullish technicals - Traders Union
BeOne Medicines (ONC) Secures Rights To Four RAS(ON) Inhibitors In Asia - Sahm
BeOne Medicines (NASDAQ:ONC) SVP Sells 2,666 Shares of Stock - MarketBeat
Insider Selling: BeOne Medicines (NASDAQ:ONC) CEO Sells $25,661,243.30 in Stock - MarketBeat
BeOne Medicines (NASDAQ:ONC) CEO Sells $19,659,569.80 in Stock - MarketBeat
Generali Investments Management Co LLC Buys Shares of 8,000 BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
The Manufacturers Life Insurance Company Trims Stake in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Charles Schwab Trust Co Acquires New Position in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
BeOne Medicines (NASDAQ:ONC) Sees Unusually-High Trading VolumeStill a Buy? - MarketBeat
Dimensional Fund Advisors LP Raises Position in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
BeOne Medicines shares gain about 5.5% after robust Q2 results and new Phase 3 trials announcement - Traders Union
BeOne Medicines Q2 Earnings Call Highlights - sharewise.com
BeOne Medicines (NASDAQ:ONC) CFO Sells $361,805.47 in Stock - MarketBeat
Countdown to BeOne Medicines Ltd.Sponsored ADR (ONC) Q2 Earnings: A Look at Estimates Beyond Revenue and EPS - Yahoo Finance
Insider Selling: BeOne Medicines (NASDAQ:ONC) SVP Sells 1,044 Shares - MarketBeat
65,456 Shares in BeOne Medicines Ltd.Sponsored ADR $ONC Bought by Renaissance Technologies LLC - MarketBeat
ADAR1 Capital Management LLC Makes New Investment in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Insider Selling: BeOne Medicines (NASDAQ:ONC) CEO Sells $15,086,671.00 in Stock - MarketBeat
Rokos Capital Management LLP Purchases Shares of 14,335 BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
BR:B1ME34 Stock Latest News - TipRanks
BeOne Medicines AG (ONC) stock price, news, quote and history - Yahoo Finance Singapore
ONC Stock Quote Price and Forecast - CNN
Siren L.L.C. Has $138.09 Million Stock Position in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Temasek Holdings Private Ltd Cuts Stock Position in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
ABN Amro Investment Solutions Has $14.12 Million Stake in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
SEB Asset Management AB Invests $16.65 Million in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Jennison Associates LLC Purchases 78,027 Shares of BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Assetmark Inc. Increases Stock Holdings in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
AIA Group Ltd Acquires 3,430 Shares of BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
BeOne Medicines (ONC) Sets Q2 2026 Results Date As Undervaluation Narrative Builds - Sahm
BeOne Medicines (NASDAQ:ONC) CEO Sells 145,861 Shares of Stock - MarketBeat
BeOne Medicines (NASDAQ:ONC) CEO John Oyler Sells 11,698 Shares - MarketBeat
BeOne Medicines (NASDAQ:ONC) CEO John Oyler Sells 48,520 Shares of Stock - MarketBeat
Candriam S.C.A. Grows Stake in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Beone Medicines Ltd Adr (ONC) 財務データ
収益
当期純利益
現金流量
EPS
Beone Medicines Ltd Adr (ONC) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Wang Xiaodong | Chair, Scientific Advisory Brd |
Sep 08 '26 |
Sale |
349.10 |
38,287 |
13,366,092 |
0 |
大文字化:
|
ボリューム (24 時間):